SI-BONE, Inc. (SIBN) News
Filter SIBN News Items
SIBN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest SIBN News From Around the Web
Below are the latest news stories about SI-BONE INC that investors may wish to consider to help them evaluate SIBN as an investment opportunity.
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 64.71%: Here's is How to TradeThe average of price targets set by Wall Street analysts indicates a potential upside of 64.7% in Si-Bone (SIBN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. |
Wall Street Analysts See an 83.56% Upside in Si-Bone (SIBN): Can the Stock Really Move This High?The consensus price target hints at an 83.6% upside potential for Si-Bone (SIBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024SANTA CLARA, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Piper Sandler Healthcare Conference in New York. Management will be hosting a fireside chat on Wednesday, December 4, 2024, at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time. Investors interested in listening to the conference call may do so by registering at this link: ht |
SI-BONE, Inc. (NASDAQ:SIBN) Just Released Its Third-Quarter Earnings: Here's What Analysts ThinkThere's been a major selloff in SI-BONE, Inc. ( NASDAQ:SIBN ) shares in the week since it released its quarterly... |
SI-BONE Third Quarter 2024 Earnings: EPS Beats ExpectationsSI-BONE ( NASDAQ:SIBN ) Third Quarter 2024 Results Key Financial Results Revenue: US$40.3m (up 19% from 3Q 2023). Net... |
Q3 2024 SI-BONE Inc Earnings CallQ3 2024 SI-BONE Inc Earnings Call |
SI-BONE Inc (SIBN) Q3 2024 Earnings Call Highlights: Record Revenue and Path to ProfitabilitySI-BONE Inc (SIBN) reports a 19% revenue growth and significant strides towards profitability despite challenges from hurricanes and supply issues. |
Si-Bone (SIBN) Reports Q3 Loss, Lags Revenue EstimatesSi-Bone (SIBN) delivered earnings and revenue surprises of 27.27% and 0.36%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? |
Si-Bone: Q3 Earnings SnapshotSIBN) on Tuesday reported a loss of $6.6 million in its third quarter. On a per-share basis, the Santa Clara, California-based company said it had a loss of 16 cents. The results topped Wall Street expectations. |
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates GuidanceExpects to achieve positive Adjusted EBITDA in Fourth Quarter 2024SANTA CLARA, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving sacropelvic disorders, today reported financial results for the quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights (any comparisons are to the prior year period) Worldwide revenue of $40.3 million, representing growth of ~19% U.S. revenue of $38.3 million, representing growth of ~ |